Green Thumb Industries (GTBIF) Non-Current Debt (2019 - 2026)
Green Thumb Industries (GTBIF) reported Non-Current Debt of $266.3 million for Q1 2026, up 86.91% on a YoY basis from $142.5 million in Q1 2025, and up 17.64% quarter-over-quarter from $226.4 million in Q4 2025.
Green Thumb Industries (GTBIF) Non-Current Debt (2019 - 2026) Analysis & Trends
Green Thumb Industries has reported Non-Current Debt for 8 years, with the latest figure at $266.3 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Debt rose 86.91% year-over-year to $266.3 million; the trailing twelve-month figure through Mar 2026 stood at $266.3 million (up 86.91% YoY), and the FY2025 full-year result was $226.4 million, down 6.79% from the prior year.
- Non-Current Debt for Q1 2026 stood at $266.3 million, up from $226.4 million in the prior quarter.
- The five-year high for Non-Current Debt was $306.9 million in Q1 2024, with the low at $82.5 million in Q2 2024.
- Historically, Non-Current Debt has averaged $245.4 million across 5 years, with a median of $252.4 million in 2022.
- Annual changes were most pronounced in 2024 — Non-Current Debt tumbled 71.45% — and 2025, when it surged 183.8%.
- Green Thumb Industries' Non-Current Debt stood at $274.6 million in 2022, then increased by 11.25% to $305.5 million in 2023, then dropped by 20.5% to $242.9 million in 2024, then retreated by 6.79% to $226.4 million in 2025, then advanced by 17.64% to $266.3 million in 2026.
- The last three Non-Current Debt figures came in at $266.3 million (Q1 2026), $226.4 million (Q4 2025), and $230.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 569.60 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Green Thumb Industries | - | - | 143.65 Mn | 266.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 266.34 Mn |
| Mar 31, 2026 | 266.34 Mn |
| Dec 31, 2025 | 226.40 Mn |
| Dec 31, 2025 | 226.40 Mn |
| Sep 30, 2025 | 230.19 Mn |
| Sep 30, 2025 | 230.19 Mn |
| Jun 30, 2025 | 234.07 Mn |
| Jun 30, 2025 | 234.07 Mn |
| Mar 31, 2025 | 142.50 Mn |
| Mar 31, 2025 | 142.50 Mn |
| Dec 31, 2024 | 242.90 Mn |
| Dec 31, 2024 | 242.90 Mn |
| Sep 30, 2024 | 246.18 Mn |
| Sep 30, 2024 | 246.18 Mn |
| Jun 30, 2024 | 82.48 Mn |
| Jun 30, 2024 | 82.48 Mn |
| Mar 31, 2024 | 306.90 Mn |
| Mar 31, 2024 | 306.90 Mn |
| Dec 31, 2023 | 305.53 Mn |
| Dec 31, 2023 | 305.53 Mn |